Friday, 22 February 2019

Contract Manufacturing News

  • China marches ahead with regulatory approvals

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2012

    After five years of amendments and two rounds of public consultations, the State Food and Drug Administration (SFDA) issued Good Manufacturing Practice for Drugs that came into effect on Ma...Read more

  • Shire biologics facility gets FDA clearance

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

    Singapore: Shire, global specialty biopharmaceutical company, has recieved US FDA approval for production of VPRIV drug substance (velaglucerase alfa for injection) in Shire's manufacturing...Read more

  • ScinoPharm clocks $167 mn in 2013

    Contract Manufacturing |  Company results | By BioSpectrum Bureau  | 0 Comment | 17 Feb, 2014

    Singapore: ScinoPharm, Taiwan-based active pharmaceutical ingredient (API) specialty company, has clocked $167.60 million in revenue, up 11 percent over 2012 with after-tax net profits of $...Read more

  • Sanofi, Isarna enter manufacturing agreement

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2014

    Singapore: Isarna Therapeutics has signed a strategic manufacturing agreement with Sanofi under which Sanofi will manufacture clinical- and commercial-grade antisense oligonucleotide (ASO) ...Read more

  • US FDA finds cGMP violation at Taiwan facility

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jan, 2013

    Singapore: The US Food and Drug Administration (FDA) has issued a warning letter to Taiwan Three Mast Pharmaceutical after an inspection of their pharmaceutical manufacturing facility in Ta...Read more

  • WuXi facility gets SFDA certificate

    Contract Manufacturing |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2012

    Singapore: The toxicology facility of WuXi PharmaTech at Suzhou, China, has received a certificate of Good Laboratory Practice (GLP) from the State Food and Drug Administration (SFDA) of th...Read more

  • West sets up manufacturing facility in South India

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2012

    Bangalore: West Pharmaceutical India Packaging, an indirect subsidiary of West Pharmaceutical Services, US, hosted a ceremony to mark the start of construction of its new compression moldi...Read more

  • WuXi Pharma to manufacture Ibalizumab for TaiMed

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2012

    Singapore: WuXi PharmaTech entered into a contract manufacturing agreement with TaiMed Biologics for the manufacture of ibalizumab (TMB-355) in support of phase II and phase III clinical t...Read more

  • DSM launches cGMP facility in Brisbane

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2013

    Singapore: DSM Pharmaceutical, the custom manufacturing and technology business of Royal DSM, has launched its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, Au...Read more

  • Merck France unit plant gets compliance certification

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2013

    September: Merck Millipore has received good manufacturing practice certification for its Biodevelopment Center in France, certified by the French National Agency for Medicines and Health P...Read more

  • Telstar to set up plants for Square in Bangladesh

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

    Singapore: Telstar, a provides of life sciences solutions headquartered in Spain, will set up two new pharmaceutical plants for the Bangladesh-based firm Square Pharmaceuticals. Square is t...Read more

  • Temasek to divest in Medreich Pharma

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Bangalore: Temasek, a Singapore-based investment company with 11 affiliates and offices in Asia and Latin America, is looking to offload its stake in Bangalore-based Medreich Pharma. Temas...Read more

  • Tiyanyin Pharma recieves GMP certification

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2014

    Singapore: China-based Tianyin Pharmaceutical has received good manufacturing practice (GMP) certification under certificate number Chuan K0592, valid until December 31, 2015 for its tablet...Read more

  • Shasun, Debiopharm to manufacture brain drug

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 11 Apr, 2013

    Singapore: Shasun Pharmaceuticals and Debiopharm Group entered into a licensing agreement for the manufacturing and commercialization of Huperzine-A. The drug is a potent and reversible ace...Read more

  • ScinoPharm to manufacture Supernus epilepsy drug

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2013

    Singapore: Taiwan-based ScinoPharm will provide commercial manufacturing of topiramate active pharmaceutical ingredient (API) for Trokendi XR, which was developed and recently launched by S...Read more

  • Lilly expands partnership with Novast

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its network of manufacturing capabilities in this key emerging market co...Read more

  • Kimball's China facility achieves ISO certification

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Kimball Electronics Group, a subsidiary of Kimball International, announced that the company's production facility in Nanjing, China, has achieved the stringent ISO 13485 certifi...Read more

  • ScinoPharm, TaiGen collaborate for stem cell drug

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jun, 2014

    Singapore: Taiwan based ScinoPharm, engaged in development and manufacture of active pharmaceutical ingredients has closed a contract manufacturing deal for the clinical supply of the API o...Read more

Podcast

 

Survey Box

Is Asia Pacific anticipated to be the fastest growing blockchain in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls